Serum C-reactive protein and C-reactive protein derived markers in diabetic microvascular complications

Figure 1 Association between C-reactive protein, high sensitivity C-reactive protein, C-reactive protein to lymphocyte count ratio and C-reactive protein to lymphocyte count ratio levels and type 2 diabetes mellitus and diabetic complications. Both C-reactive protein, high sensitivity C-reactive protein, C-reactive protein to albumin ration and C-reactive protein to lymphocyte count ratio are increased in patients with type 2 diabetes mellitus and with diabetic microvascular complications. Moreover, elevated levels of these markers are associated with poor disease control in diabetic population. T2DM: Type 2 diabetes mellitus; CRP: C-reactive protein; Hs-CRP: High sensitivity C-reactive protein; CAR: C-reactive protein to albumin ratio; CLR: C-reactive protein to lymphocyte count ratio; IL-6: Interleukin-6; TNF-α: Tumor necrosis factor-α; DN: Diabetic nephropathy; DR: Diabetic retinopathy; DPN: Diabetic peripheral neuropathy.